Clinical Trial Update: Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and tolerability of the nutraceutical Coleosoma in dyslipidemia subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Coleosoma

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Parma | Conditions: Dyslipidemias | Phase 2 | Status: COMPLETED